Salmonella enterica serovar Typhimurium is one of the most common causes of foodborne gastroenteritis worldwide, responsible for millions of infections each year through contaminated eggs, poultry, produce, and other foods. Despite sharing a genus with the bacterium that causes typhoid fever, S. Typhimurium typically produces a different, self-limiting illness in people. What makes this organism so fascinating to microbiologists, and so frustrating to public health officials, is its extraordinary versatility: it thrives in the human gut, survives inside immune cells meant to kill it, forms stubborn biofilms on surfaces from stainless steel to gallstones, infects plants, and has even been engineered as an experimental cancer therapy.
Discovery, Naming, and Where It Fits
The organism was first identified in 1884 by Theobald Smith and named after his mentor, Daniel Salmon. The genus name Salmonella was formally adopted in 1934. Today the genus belongs to the family Enterobacteriaceae and contains two recognized species: S. enterica and S. bongori. S. enterica is further divided into six subspecies, with almost all human disease caused by subspecies I (enterica). Within that subspecies, a serotyping scheme originally developed by Kauffmann and White has defined over 2,600 serovars based on surface antigens. Typhimurium is one of the most intensely studied of these serovars, in part because it infects a wide range of animal hosts and is easy to grow in the laboratory.1Microbiology Society (PMC). Microbe Profile: Salmonella Typhimurium: the master of the art of adaptation
Getting Past Stomach Acid
Before S. Typhimurium can reach the intestine, it has to survive the stomach, where pH can drop below 2. The bacterium manages this through a defense system called the acid tolerance response, which kicks in when cells are first exposed to mildly acidic conditions. This priming step triggers the production of specialized proteins that protect the cell’s interior when it later encounters the extreme acidity of the stomach.2PubMed Central. The acid tolerance response of Salmonella typhimurium involves transient synthesis of key acid shock proteins The response works against both the inorganic acid of gastric juice and organic acids encountered in fermented or acidic foods.3PubMed. The acid tolerance response of Salmonella typhimurium provides protection against organic acids A key regulatory system called PhoPQ helps orchestrate the protective response when pH drops.4PubMed Central. A low pH-inducible, PhoPQ-dependent acid tolerance response protects Salmonella typhimurium against inorganic acid stress
This acid survival trick is one reason the infectious dose for Salmonella can be surprisingly low when bacteria arrive in fatty or buffered foods like cheese, chocolate, or peanut butter, where the food itself partially shields the organisms from stomach acid. A person eating contaminated food on a full stomach may be at greater risk than someone on an empty stomach, because the food raises gastric pH just enough to let more bacteria through.
Invading the Gut Lining
Once past the stomach, S. Typhimurium targets the epithelial cells lining the small intestine. It crosses this barrier using a molecular syringe called a type III secretion system, encoded on a stretch of DNA known as Salmonella pathogenicity island 1 (SPI-1). The syringe injects bacterial proteins directly into the host cell, triggering the cell to ruffle its membrane and engulf the bacterium, essentially tricking cells that would not normally take up bacteria into swallowing them.5PubMed. Adaptation to the host environment: regulation of the SPI1 type III secretion system in Salmonella enterica serovar Typhimurium Mutant bacteria that lack a functional SPI-1 system invade roughly five times less efficiently than normal strains.6PubMed Central. SPI-1-encoded type III secretion system of Salmonella enterica is required for the suppression of porcine alveolar macrophage cytokine expression
The same SPI-1 system does double duty: besides forcing entry into gut cells, it also suppresses the early alarm signals that immune cells called macrophages would otherwise broadcast. When macrophages encounter SPI-1-deficient mutants, they ramp up production of inflammatory signaling molecules. Wild-type bacteria, equipped with the full syringe, dampen that initial immune response, buying time to establish infection.7PubMed Central. SPI-1-encoded type III secretion system of Salmonella enterica is required for the suppression of porcine alveolar macrophage cytokine expression
Surviving Inside Immune Cells
Most bacteria that get swallowed by a macrophage are quickly destroyed. S. Typhimurium turns this would-be death sentence into a safe house. Once inside, the bacterium remodels the compartment around it into a specialized niche called the Salmonella-containing vacuole. A second molecular syringe, encoded on pathogenicity island 2 (SPI-2), is essential for this phase. While SPI-1 handles invasion, SPI-2 handles intracellular survival.8PubMed. The mechanism of Salmonella entry determines the vacuolar environment and intracellular gene expression Additional survival tools include genes on a large virulence plasmid and a regulatory system called PhoP-PhoQ, the same system that helps the bacterium tolerate stomach acid.9PubMed. Trafficking of the Salmonella vacuole in macrophages
The host’s innate immune system does not take this lying down. Pattern recognition receptors on and inside cells detect Salmonella components and trigger inflammation. Signaling molecules like interleukin-23 help coordinate the immune response in the gut lining, driving recruitment of neutrophils and other immune cells to the site of infection.10PubMed Central. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine But the bacterium does not just passively endure this inflammatory assault. It actively exploits the consequences.
Turning Gut Inflammation Into a Competitive Edge
This is perhaps the cleverest trick in S. Typhimurium’s playbook. The inflammation the host mounts against the bacterium produces reactive oxygen species, the same molecules your body uses as antimicrobial weapons. These reactive molecules react with sulfur compounds naturally present in the gut to generate tetrathionate. Most gut bacteria cannot use tetrathionate, but S. Typhimurium can. It breathes tetrathionate the way we breathe oxygen, using it as an electron acceptor for a type of respiration that gives it a massive growth advantage over the fermenting bacteria that normally dominate the gut.11PubMed Central. Gut inflammation provides a respiratory electron acceptor for Salmonella
The advantage goes further. Using tetrathionate-fueled respiration, S. Typhimurium can also feed on ethanolamine, a nutrient released from damaged gut-lining cells that most competing microbes cannot metabolize under the oxygen-free conditions of the gut.12PubMed Central. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota In effect, the bacterium provokes inflammation, then uses the chemical fallout to outcompete the trillions of resident microbes that normally keep pathogens in check. It is the biological equivalent of starting a fire and then being the only one with a fireproof suit.
Different Hosts, Different Diseases
One of the more confusing aspects of S. Typhimurium is that it causes different diseases depending on the host. In humans, it typically produces self-limiting gastroenteritis: diarrhea, cramps, and fever lasting a few days. In mice, however, the same serovar causes a systemic, typhoid-like illness with bacteria spreading to the liver and spleen. This difference is why mouse infections with S. Typhimurium have long served as the primary laboratory model for studying typhoid fever, even though typhoid in humans is caused by a different serovar (S. Typhi) that is restricted to human hosts. Calf infections with S. Typhimurium, on the other hand, more closely mimic the intestinal disease seen in people, making cattle a useful model for understanding gastroenteritis.13PubMed. Animal models of Salmonella infections: enteritis versus typhoid fever
The host-dependent differences are not just academic. They have real consequences for how research findings translate to human medicine. A drug that cures systemic S. Typhimurium in mice may not address the intestinal inflammation that matters most in human patients. Researchers have to keep these species-specific disease patterns firmly in mind when interpreting their experiments.
Invasive Disease in Sub-Saharan Africa
While S. Typhimurium in wealthy countries is typically a foodborne nuisance that resolves on its own, in sub-Saharan Africa it behaves more like a lethal systemic pathogen. Invasive non-typhoidal Salmonella disease, often caused by S. Typhimurium, produces bloodstream infections with high mortality rates, particularly in young children, people with HIV, and those with malaria or malnutrition. At least six distinct invasive clades have emerged, with a lineage called ST313 lineage 2 driving the current pandemic. This lineage likely emerged in the Democratic Republic of Congo around 1980 and spread widely through the region in the mid-1990s.14Nature Communications. A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa
The invasive strains carry genetic differences that distinguish them from the gastroenteritis-causing strains common elsewhere. Some have lost genes involved in intestinal colonization while acquiring resistance to multiple antibiotics, making them harder to treat and suggesting they have adapted to a more systemic, person-to-person transmission cycle rather than the classic food-animal-to-human route.
The Antibiotic Resistance Problem
Resistance in S. Typhimurium is not limited to Africa. One of the most alarming developments was the global emergence of phage type DT104, which became a major concern from the 1990s onward. DT104 strains are typically resistant to five drugs: ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline.15PubMed Central. Salmonella typhimurium DT104: a virulent and drug-resistant pathogen Unlike many resistant bacteria that carry their resistance genes on easily lost plasmids, DT104 has its resistance genes clustered directly on the chromosome, making them a stable, permanent feature of the strain.16PubMed. Molecular characterization, spread and evolution of multidrug resistance in Salmonella enterica typhimurium DT104
DT104 spread through cattle, pigs, poultry, and wild animals on multiple continents. Investigation of outbreaks in livestock showed that transmission did not depend solely on trading live animals. Sharing equipment between farms, human contacts between herds, and contaminated slurry all played roles, meaning that an infected herd posed a risk to neighboring farms even without direct animal-to-animal contact.17Oxford Academic (Journal of Applied Microbiology). Transmission routes of Salmonella Typhimurium DT 104 between 14 cattle and pig herds in Denmark demonstrated by molecular fingerprinting
Biofilms, Gallstones, and Chronic Carriage
S. Typhimurium does not always cause acute illness and move on. Like its relative S. Typhi, it can establish long-term residence in the gallbladder, particularly when gallstones are present. The bacterium forms biofilms on the surfaces of cholesterol gallstones, using structures including type 1 fimbriae (tiny hair-like appendages) and specific outer membrane proteins to attach and persist.18PubMed Central. Identification of Salmonella enterica serovar Typhimurium genes regulated during biofilm formation on cholesterol gallstone surfaces For S. Typhi specifically, this chronic gallbladder colonization with biofilm formation has been epidemiologically linked to gallbladder cancer, sustained by ongoing inflammatory damage to the gallbladder lining.19PubMed Central. Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer
Beyond the gallbladder, S. Typhimurium forms biofilms on a wide variety of surfaces relevant to food processing. The composition and resilience of these biofilms depend on factors like temperature and the strain’s ability to produce cellulose. Research has shown that some strains secrete cellulose more effectively at cooler temperatures, around 15°C, and that the accumulation of polysaccharides in the biofilm matrix increases resistance to disinfectants.20LWT. Comparative study of Salmonella Typhimurium biofilms and their resistance depending on cellulose secretion and maturation temperatures Flagella, fimbriae, and cellulose all contribute to attachment to surfaces, including plant cell walls, and these components are produced at different levels depending on temperature.21PubMed Central. Role of Fimbriae, Flagella and Cellulose on the Attachment of Salmonella Typhimurium ATCC 14028 to Plant Cell Wall Models
Contaminating Fresh Produce
The ability to attach to plant surfaces is not just a laboratory curiosity. S. Typhimurium can use plants as genuine alternative hosts, not merely passive vehicles. The bacterium adheres to leaves and roots, and can actively invade the interior of plant tissues using the same type III secretion system it deploys against animal cells. It even suppresses plant defense responses, suggesting a dedicated multi-host infection strategy that evolved to work across biological kingdoms.22Trends in Plant Science. Plants as alternative hosts for Salmonella
Once internalized within leaf tissue, the bacteria become extremely difficult to remove by washing or standard disinfection, because they are physically shielded inside the plant cells.23PubMed Central. Internalization of Salmonella in Leafy Greens and Impact on Acid Tolerance This reality underlies the recurring outbreaks linked to lettuce, sprouts, tomatoes, and other produce that is eaten raw. No amount of rinsing will reliably eliminate bacteria hiding inside the leaf itself. Prevention depends more on keeping irrigation water, soil, and handling environments free from contamination in the first place.
Tracking Outbreaks With Whole Genome Sequencing
Traditional outbreak investigation relied on serotyping, phage typing, and molecular fingerprinting methods that could group isolates into broad categories but often lacked the resolution to distinguish between truly related cases and unrelated infections that happened to share the same common type. Whole genome sequencing has changed the game. By comparing the full DNA sequence of bacterial isolates, public health labs can now identify clusters of cases separated by just a handful of single-nucleotide differences.
In a mayonnaise-linked outbreak, for instance, all outbreak-associated isolates formed a tightly clustered group with a maximum pairwise distance of only three nucleotide changes, clearly distinguishing them from unrelated strains of the same phage type.24PLOS Currents Outbreaks. Whole Genome Sequencing of Salmonella enterica Serovar Typhimurium DT8 Used to Investigate an Outbreak Associated with Mayonnaise In Australia, genomic analysis was able to distinguish distinct foodborne outbreaks among isolates that shared identical molecular fingerprinting profiles, and could also differentiate sporadic cases from outbreak cases within groups that older methods lumped together.25PubMed Central. Whole genome sequencing of Salmonella Typhimurium illuminates distinct outbreaks caused by an endemic multi-locus variable number tandem repeat analysis type in Australia, 2014 Danish surveillance demonstrated that whole-genome comparison could not only identify all known outbreaks but also link them to specific food and animal sources, and pull in additional human cases that earlier methods had missed.26PubMed Central. Investigation of Outbreaks of Salmonella enterica Serovar Typhimurium and Its Monophasic Variants Using Whole-Genome Sequencing, Denmark
Vaccination in Poultry
Because much human exposure to S. Typhimurium traces back to food animals, controlling the bacterium in poultry flocks is a major public health strategy. Both live attenuated and inactivated vaccines exist, and each comes with trade-offs. Live vaccines stimulate stronger mucosal and systemic immunity but carry theoretical risks of persistence or reversion to virulence. Inactivated vaccines are safer and more widely accepted by regulators but generally need multiple doses and produce weaker immune responses.27Journal of Applied Poultry Research. Role of vaccines in Salmonella control — a review
In laying hens, trials have shown that oral live vaccines alone may not provide lasting protection against gut colonization. An inactivated vaccine given twice offered significant protection, and a live vaccine administered by injection rather than orally produced the most durable results across multiple time points.28PubMed Central. Live and inactivated vaccine regimens against caecal Salmonella Typhimurium colonisation in laying hens In practice, the most effective programs combine vaccination with biosecurity measures and ongoing surveillance rather than relying on any single intervention.
Phage Therapy for Food Safety
Bacteriophages, viruses that infect and kill bacteria, are attracting serious interest as a way to control Salmonella on food products without antibiotics or chemical preservatives. Because phages are highly specific, targeting particular bacterial species while leaving everything else untouched, they can be applied to ready-to-eat foods without altering taste, texture, or the broader microbial ecosystem.
One well-studied phage, FO1-E2, was tested against S. Typhimurium on several ready-to-eat foods. At refrigerator temperatures, phage treatment eliminated all detectable Salmonella cells, a reduction of more than a thousandfold. At slightly warmer storage temperatures, the phage still reduced bacterial counts by a factor of up to one hundred thousand on turkey deli meat and in chocolate milk.29PubMed. Biocontrol of Salmonella Typhimurium in RTE foods with the virulent bacteriophage FO1-E2 More recently, newly isolated phages have shown the ability to reduce S. Typhimurium counts in milk by roughly a hundredfold within a few hours.30PubMed Central. Isolation and Characterization of Two Novel Lytic Bacteriophages against Salmonella typhimurium and Their Biocontrol Potential in Food Products Several phage-based products have already received regulatory approval for use in food processing in some countries, though widespread adoption is still in its early stages.
Engineered Salmonella as Cancer Therapy
In one of the more surprising chapters of S. Typhimurium research, scientists have been deliberately engineering attenuated strains of the bacterium to target tumors. The rationale is that Salmonella naturally accumulates in solid tumors, probably because the oxygen-poor, immune-suppressed tumor microenvironment provides a favorable niche. Researchers have taken advantage of this tumor-homing tendency by stripping away the bacterium’s disease-causing ability and then arming it with therapeutic payloads.31ACS Synthetic Biology. Multiplexed Engineering of Salmonella Typhimurium for Targeted Cancer Therapies
In mouse studies, an attenuated S. Typhimurium strain engineered to secrete a flagellin protein from a different bacterium effectively suppressed tumor growth and metastasis and extended survival.32PubMed. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin Other work has explored cell-wall-deficient forms of attenuated S. Typhimurium that can induce programmed cell death in ovarian cancer cells and reduce the expression of proteins that promote tumor growth and spread in mice.33Scientific Reports. Attenuated Salmonella typhimurium L forms suppress tumor growth and promote apoptosis in murine ovarian tumors These are still experimental approaches, with no approved human therapies yet, but the work illustrates how deeply scientists understand S. Typhimurium’s biology and how that knowledge can be redirected toward medicine.
What Happens in Microgravity
S. Typhimurium has also been to space. Experiments aboard the Space Shuttle found that spaceflight altered the expression of 167 genes and 73 proteins in the bacterium, and the space-flown bacteria showed increased virulence when used to infect mice after landing. The bacteria also accumulated more extracellular matrix, consistent with enhanced biofilm formation. A global regulatory protein called Hfq was identified as a likely master switch in the bacterium’s response to the low-fluid-shear conditions of microgravity.34PubMed Central. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq Ground-based experiments simulating microgravity have reproduced many of these findings and shown that the conditions can also improve bacteria’s ability to handle subsequent stresses like changes in acidity, salt concentration, or exposure to antimicrobials.35PubMed Central. Spaceflight and modeled microgravity effects on microbial growth and virulence
These findings matter beyond space exploration. The low-fluid-shear conditions simulated in microgravity experiments actually resemble conditions the bacterium encounters in certain parts of the human body, such as the spaces between intestinal villi. Understanding how S. Typhimurium senses and responds to mechanical forces in its environment has opened up new avenues for studying how it behaves during actual human infection, and the Hfq regulator identified in spaceflight studies has since become an important target in broader virulence research.